InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
+3.7%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Serafini-Lamanna Tony, Vice-Président Exécutif, Diagnostics. Officer active across 1 company, notably Meridian Bioscience INC. Aggregated, 7 filings have been recorded. History available since 4 November 2021. The latest transaction was disclosed on 15 November 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
7,945 sharesCommon StockSEC:0001567619-23-001527:0
3,666 shares@ US$31.8349.4% of flowCommon StockSEC:0001127602-22-025893:0
788 shares@ US$32.0111.3% of flowCommon StockSEC:0001127602-22-025088:0
357 shares@ US$32.145.0% of flowCommon StockSEC:0001127602-22-023692:0
2,232 shares@ US$20.160.052% mcap50.0% of flowCommon StockSEC:0001127602-21-031113:0
24,343 sharesCommon StockSEC:0001127602-21-029300:0
10,593 shares0Common StockSEC:0001127602-21-028577:0
7 of 7 declarations
About Serafini-Lamanna Tony
Tony Serafini-Lamanna is Executive Vice President, Diagnostics at Meridian Bioscience Inc. In this role, he oversees diagnostics-related operations and contributes to product innovation. Tony brings valuable expertise in the life sciences sector, playing a key role in developing advanced diagnostic solutions. His leadership is essential in strengthening Meridian's position in the market.
